Hyperactivation of the PI3K/AKT/mTOR signaling pathway has previously been reported to be central to the control of cell viability, apoptosis, cell cycle, metabolism, and chemoresistance in multiple human cancers, including USC. This evidence concerns the gene PIK3CA and cancer.